Denosumab in breast cancer patients receiving aromatase inhibitors: A single-center observational study of effectiveness in adjuvant setting

Indian J Cancer. 2021 Jan-Mar;58(1):136-139. doi: 10.4103/ijc.IJC_16_20.

Authors

Azzurra Irelli¹, Maria Maddalena Sirufo², Teresa Scipioni¹, Francesca De Pietro², Amedeo Pancotti², Lia Ginaldi², Massimo De Martinis²

Affiliations

¹ Medical Oncology Unit, Department of Oncology, AUSL 04 Teramo, Italy.
² Allergy and Clinical Immunology Unit, Center for the Diagnosis and Treatment of Osteoporosis, AUSL 04 Teramo; Department of Life, Health and Environmental Sciences, University of L'Aquila, Italy.

PMID: 33402577
DOI: 10.4103/ijc.IJC_16_20

No abstract available

Publication types

Letter

MeSH terms

Aromatase Inhibitors / therapeutic use*
Breast Neoplasms / drug therapy*
Breast Neoplasms / pathology
Denosumab / pharmacology
Denosumab / therapeutic use*
Female
Humans

Substances

Aromatase Inhibitors
Denosumab